How do I know if buprenorphine or methadone is the right choice for me?

Choosing between buprenorphine and methadone for medication-assisted treatment for long-term stability comes down to your lifestyle, medical history, and personal preferences. Buprenorphine is often prescribed in an office or even via telehealth, giving you more flexibility and privacy. Methadone, on the other hand, is typically dispensed daily at specialized clinics, which provides more structure and in-person monitoring. Some people find buprenorphine’s lower risk of overdose appealing, while others prefer methadone’s strong track record for keeping folks in treatment longer, especially if they’ve had multiple relapses[ref_2]. If you have a busy schedule or need a more flexible option, buprenorphine is usually a better fit. Methadone may suit those needing extra accountability or who haven’t responded to other options.

Medication-assisted treatment for long-term stability proven effective

Key Takeaways

Holistic Approach: MAT is most effective when combined with trauma-informed therapy and family support, not just medication alone.
Brain Chemistry: Medications like buprenorphine or naltrexone stabilize neural pathways, reducing cravings without creating a “high.”
Proven Retention: Evidence shows that MAT significantly increases the likelihood of staying in treatment and reduces overdose mortality by approximately 50%.
Customized Care: Treatment plans should be tailored to your specific needs, moving through levels of care from detox to residential and outpatient support.

What Medication-Assisted Treatment for Long-Term Stability Means for Recovery

Beyond Medication: The Full Picture

When we talk about medication-assisted treatment for long-term stability, it is easy to picture just the prescription bottle. However, the real impact of MAT comes from a much broader approach that blends medication, therapy, and strong support systems. At Breathe, we view this as a partnership between medical science and compassionate human connection.

Our experience shows that medications like buprenorphine or naltrexone act as anchors—they reduce cravings and withdrawal, making it possible for you to focus on healing. Yet, those results multiply when counseling and group support enter the picture. For instance, a Georgia program that added regular cognitive behavioral therapy (CBT) to MAT saw retention rates jump from 8% to 56%, simply by making sure people had consistent counseling alongside their medication³.

We have seen that recovery is not just about staying off a substance; it is about building a life worth living. That means integrating trauma-informed therapy, family involvement, and skills-building workshops, which can help you manage stress, repair relationships, and rediscover your passions. The science backs this up: combining psychosocial support with MAT significantly improves both retention in treatment and overall well-being⁴.

This holistic model is why we frame MAT as a full recovery partnership, not a quick fix. We treat every client like a loved one, ensuring that the clinical approach is as robust as the medical one.

Who Benefits Most from MAT

Understanding who stands to gain the most from medication-assisted treatment for long-term stability is crucial for maximizing its impact. While MAT is most widely known for treating opioid use disorder, it is especially suited to people who have tried to quit multiple times without lasting results, or for those at higher risk of relapse or overdose.

This approach is ideal for individuals with a history of chronic opioid use. Research shows that medications like naltrexone or buprenorphine can reduce overdose mortality by about 50% compared to those who do not receive these treatments². For folks leaving correctional settings, the benefits are even more pronounced—a Massachusetts study found a 52% lower risk of fatal overdose among people who received MAT during incarceration¹.

We have also seen MAT work well for those juggling complex challenges, such as co-occurring mental health conditions, unstable housing, or limited support at home. For example, many of our clients struggling with both addiction and anxiety have found that the structure of MAT provides a foundation for healing on multiple fronts.

This solution fits anyone who needs not just symptom relief, but a real shot at rebuilding their life—with clinical support and a safety net. Next up, we will explore how these medications actually work in the brain to support lasting recovery.

How MAT Medications Work in Your Brain

When you start Medication-Assisted Treatment, you are working with medications that interact directly with the same brain receptors affected by opioids or alcohol. These are not just masking symptoms; they are actually helping restore balance to neural pathways that addiction has fundamentally changed.

To understand why this is effective, we need to look at the biology. Opioid receptors exist naturally in your body to regulate pain, reward, and emotional responses. When you use opioids repeatedly, your brain stops producing its own natural endorphins and becomes dependent on the external supply, creating a biological crisis when you stop using.

Here is a breakdown of how the primary MAT medications interact with your system:

Medication	Mechanism	How It Helps
Buprenorphine (Suboxone/Subutex)	Partial Agonist	Creates a “ceiling effect” where taking more doesn’t produce more euphoria, making misuse far less likely while quieting cravings.
Naltrexone	Opioid Antagonist	Blocks receptors completely. If you use opioids or alcohol, you won’t feel the euphoric reward, breaking the cycle of reinforcement.
Acamprosate	Neurotransmitter Balancer	Restores balance to glutamate and GABA systems, reducing the physical and emotional discomfort of early alcohol sobriety.

Most patients report reduced cravings within 24-48 hours of starting buprenorphine, and many find this gives them mental clarity they haven’t experienced in years. By stabilizing these neurochemical pathways, you regain the ability to engage meaningfully in therapy.

“Research shows that MAT can reduce opioid overdose deaths by more than 50% and improve treatment retention rates to above 75%, compared to less than 25% for behavioral therapy alone.”

Your brain didn’t develop addiction overnight, and it won’t heal overnight either. MAT provides the biological support that makes genuine healing possible, allowing you to focus on rebuilding relationships and developing life skills.

Evidence That MAT Saves Lives

Retention Rates That Actually Matter

When we are looking at what makes medication-assisted treatment for long-term stability so effective, nothing tells the story better than the numbers on retention. In real life, staying engaged in treatment is what keeps people alive and moving forward. The difference is dramatic.

Research shows that after six months, 57.5% of people receiving buprenorphine-based MAT remain in treatment, compared to just 22.8% of those not on these medications⁴. That is not just a statistic—it is a person’s chance to build momentum, reconnect with family, and start seeing hope as something real.

We have seen clients who tried to quit cold turkey return to old habits within weeks. But with MAT, they finally get the breathing room to focus on therapy, job goals, or even going back to school. Programs that combine regular counseling with MAT see even higher engagement. For instance, adding consistent cognitive behavioral therapy can boost retention rates up to seven times higher than medication alone³.

Long-Term Stability Beyond Sobriety

When we look at the real-world outcomes of medication-assisted treatment for long-term stability, the impact goes far beyond simply stopping substance use. We consistently see clients experience major improvements in their day-to-day quality of life—think better sleep, more energy, and the capacity to focus on work or relationships again.

A recent review found that people receiving MAT reported not only fewer cravings but also significant reductions in fatigue and improvements in memory compared to those on other medications or no treatment at all¹⁰. Socially, the benefits ripple outward. Many of our clients find themselves reconnecting with loved ones, regaining trust, or even stepping back into roles they once thought were lost—like parenting or steady employment.

For instance, we have supported people who, after stabilizing with MAT, were able to return to school or take on new job responsibilities they had previously avoided due to anxiety or health issues. This approach is ideal for anyone looking to reclaim a sense of normalcy and hope, not just abstinence.

Building Your Plan for Medication-Assisted Treatment for Long-Term Stability

Now that you understand what is happening in your brain during addiction, here is how we translate that science into personalized recovery plans that actually work. Creating an effective MAT treatment plan starts with a thorough clinical assessment.

When you arrive at Breathe, our multidisciplinary team—including physicians, therapists, and case managers—sits down with you for a comprehensive evaluation. We look at your substance use history, mental health background, and personal recovery goals to design a plan specifically for you. This isn’t a one-size-fits-all process.

Here is what a structured MAT pathway typically looks like with us:

Medical Stabilization (Detox): We begin with medically supervised detox to safely manage withdrawal. This is where we may introduce medications to eliminate physical cravings and ensure your safety, monitoring for risks like seizures or heart issues.
Primary Residential Treatment: Once stable, you transition to our residential program. Here, MAT continues working at the neurological level while you engage in our “Crystal Clear” curriculum (for meth recovery) or trauma-informed psychodrama sessions.
Therapeutic Integration: We integrate evidence-based therapies like Internal Family Systems (IFS) and experiential role-playing. You aren’t just talking about change; you are practicing it.
Family Involvement: We believe recovery is a family system issue. Your plan includes our 3-Day Family Workshop to reduce blame and build healthier functioning.
Aftercare & Alumni Support: Before you leave, we build a relapse prevention strategy. This includes connecting you with our BreatheOUT alumni community and ensuring ongoing medical management for your MAT medications.

Your treatment plan evolves as you progress. We reassess regularly and adjust medication dosages, therapy focus, or level of care based on how you are responding. For example, you might transition from residential care to our Partial Hospitalization Program (PHP) or Enhanced Sober Living as you gain more autonomy.

The goal isn’t just getting you stable on medication. It is equipping you with every tool you need—from nutritional stabilization to “recovery life support”—to build a life you don’t want to escape from.

Frequently Asked Questions

Can I receive MAT through telehealth, or do I need in-person visits?

You can absolutely receive medication-assisted treatment for long-term stability through telehealth. In fact, as of 2025, new federal rules allow providers to prescribe buprenorphine and other MAT medications remotely—even for first-time patients—so long as you have a phone or video consultation. This means you can get up to a six-month supply of medication without needing an in-person visit, making treatment more accessible than ever⁶.

We’ve seen this flexibility help clients who live far from clinics or have busy work and family schedules. Telehealth MAT also supports privacy and comfort, letting you connect from home while still receiving the same level of medical oversight and counseling

Will MAT medications interfere with my ability to work or drive?

Most people find that medication-assisted treatment for long-term stability actually improves their ability to function at work or behind the wheel once they’re stabilized. The goal of MAT is to reduce cravings and withdrawal—so you can focus, think clearly, and safely participate in daily activities. While starting a new medication like naltrexone or buprenorphine, you might feel drowsy or lightheaded for the first few days, but these effects typically fade as your body adjusts.

Studies suggest that, once stable on a consistent dose, most people on MAT perform as well as their peers at work and are safe to drive, unless they’re mixing medications or using other substances¹⁰. We always encourage clients to check in with their doctor about any side effects and avoid driving if they feel impaired for any reason.

What happens if I relapse while on medication-assisted treatment?

If you experience a relapse while on medication-assisted treatment for long-term stability, it’s not a sign of failure—relapse is a recognized part of the recovery process for many. The most important step is to reach out to your care team right away rather than stopping your medication or skipping appointments. We adjust your treatment plan to address new stressors, triggers, or changes in your environment, and often recommend additional support like increased therapy or a family session.

Current best practices actually discourage discharge from MAT programs after a relapse. Research shows that sticking with your care—even through setbacks—significantly boosts your chance of lasting recovery⁴. The goal is progress, not perfection; we’re here to support you through every challenge.

Does insurance typically cover MAT medications and the therapy that goes with them?

Most major insurance plans—including Medicaid, Medicare, and commercial insurers—typically cover both MAT medications and the therapy that goes along with medication-assisted treatment for long-term stability. Coverage often includes buprenorphine and naltrexone, as well as required counseling or behavioral health sessions. That said, individual plan requirements can vary, and some insurers may require pre-authorization or have limits on the number of therapy visits. The American Medical Association continues to advocate for better insurance parity and removal of barriers, but some people still run into coverage challenges or out-of-pocket costs⁷. We always help clients navigate these details and maximize their benefits so treatment can start without unnecessary delays.

How long will I need to stay on MAT medications?

There’s no one-size-fits-all timeline for staying on medication-assisted treatment for long-term stability. Most current evidence and clinical guidelines support continuing MAT as long as it’s helping you maintain recovery and avoid relapse—sometimes for years, or even indefinitely. In fact, attempts to taper off too soon often lead to high rates of relapse, which can increase the risk of overdose².

We always individualize the plan based on your goals, progress, and comfort level. Some clients thrive with long-term maintenance, while others may explore tapering with lots of support and careful monitoring. The most important thing is that you and your care team collaborate on the pace and plan that keeps you safe and stable.

Can MAT help with substances other than opioids?

Medication-assisted treatment for long-term stability is best known for treating opioid use disorder, but its role with other substances is still being explored. Currently, FDA-approved MAT options like buprenorphine and naltrexone are designed for opioids specifically. However, there is ongoing research into MAT for alcohol and stimulant use disorders—naltrexone, for example, is sometimes prescribed for alcohol dependence with positive results in reducing cravings and relapse risk⁸.

For substances like methamphetamine or cocaine, no MAT medications have official approval yet, but some clinics trial off-label approaches as part of a broader treatment plan. As research develops, we remain committed to providing the most effective, evidence-based care possible.

Your Path Forward with Breathe Life

You now understand how MAT medications can restore your brain chemistry and interrupt the relentless cycle of cravings. Let’s talk about getting you started—not someday, but this week. We are proud to hold the Joint Commission Gold Seal of Approval, ensuring that the care you receive meets the highest national standards.

Here is what happens next: When you call, our admissions team will conduct a brief assessment (typically 15-20 minutes) to understand your substance use history and current needs. We will verify your insurance benefits while you are on the phone—most plans cover MAT, and we can confirm your coverage in minutes. Within 24 hours, you will know your treatment plan and start date.

For most clients, we recommend beginning with medically supervised detox where our physicians can safely manage withdrawal while introducing MAT medications. From there, you will transition into our residential program where MAT continues working at the neurological level while you build the behavioral tools and coping strategies that sustain long-term recovery.

I have watched this evidence-based approach transform outcomes. You are not white-knuckling through cravings—you are giving your brain the neurochemical support it needs while rewiring the patterns that kept you stuck. Your dedicated case manager will coordinate every transition in your care continuum, and our alumni community provides ongoing connection long after discharge.

Recovery is a transformation, not a transaction. Call us today, complete our confidential online form, or reach out to start your journey. We accept most insurance and offer flexible payment options. Your new chapter begins with one conversation.

References

Treating Opioid Addiction in Jails Improves Treatment Engagement, Reduces Overdose Deaths, Reincarceration. https://nida.nih.gov/news-events/news-releases/2025/09/treating-opioid-addiction-in-jails-improves-treatment-engagement-reduces-overdose-deaths-reincarceration
The Effectiveness of Medication-Based Treatment for Opioid Use Disorder. https://www.ncbi.nlm.nih.gov/books/NBK541393/
Outcomes of Adding Cognitive Behavioral Therapy to Medication-Assisted Treatment for Opioid Use Disorder. https://pubmed.ncbi.nlm.nih.gov/37682021/
Models for Medication-Assisted Treatment for Opioid Use Disorder: Retention and Continuity of Care. https://aspe.hhs.gov/reports/models-medication-assisted-treatment-opioid-use-disorder-retention-continuity-care-0
Effectiveness and Safety of Therapies for Patients with Opioid Use Disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC12884343/
DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access
AMA 2025 Report on Substance Use and Treatment. https://www.ama-assn.org/press-center/ama-press-releases/ama-2025-report-substance-use-and-treatment
Medications for Opioid Use Disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder
ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. https://www.samhsa.gov/resource/ebp/asam-national-practice-guideline-treatment-opioid-use-disorder
Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes. https://pmc.ncbi.nlm.nih.gov/articles/PMC7302321/

Medication-Assisted Treatment: How It Supports Long-Term Stability